Expansion Management - Helping Companies Evaluate Future Locations EMInfo.org





 
News Home   News Archive   Search News  

  Means the article is accessible only to our magazine subscribers.

Pall Corp. to Expand Life Sciences Manufacturing in Puerto Rico

SAN JUAN, Puerto Rico (October 11, 2006) — The Pall Fajardo plant manufactures over 6,000 filtration systems for separation and purification products for biomedical, biotechnological, biopharmaceutical and industrial uses.

  [ 10/11/2006 ]  By: NEWS BRIEFS   Print This Article  Reprint/License This Article  E-mail This Article To A Friend  
  [ 0 Talkbacks / Add Talkback ]  Related Link...

Pall Corp., the global leader in filtration, separations and purification products for the biotechnology and pharmaceutical industries, will expand its Life Sciences manufacturing plant in Fajardo, Puerto Rico, by 50 percent, creating 250 new jobs and investing over $50 million in construction, machinery and equipment.

The expansion in Puerto Rico is another step in Pall's standardization of its global manufacturing footprint. The expansion will make Puerto Rico the Life Sciences Center of Excellence to Pall’s global operations.

“Puerto Rico’s attractive business climate and strong commitment to developing biopharmaceutical manufacturing capability are key factors in bringing numerous drug and biotechnology companies to the island,” said Eric Krasnoff, chairman and CEO of Pall. “Expanding our operations in Puerto Rico is an important part of our strategic approach of aligning with customers worldwide and increasing production

According to Krasnoff, the planned establishment of a Life Sciences Center of Excellence will significantly expand Pall’s capacity on the island and enhance its ability to meet the increasing demand for its high quality technologies by the world’s leading pharmaceutical and biotechnology companies, blood centers and hospitals from Puerto Rico.

The Pall Fajardo plant manufactures over 6,000 filtration systems for separation and purification products for biomedical, biotechnological, biopharmaceutical and industrial uses. Its products are most commonly used in the development of new drugs, pharmaceutical manufacturing processes, in blood filtration and intravenous treatments, and in the prevention, diagnosis and treatment of many medical conditions.

Some of its major clients include Baxter, Amgen, Merck, Genentech, Wyeth and the American Red Cross. Apart from its operations in Puerto Rico, Pall has operations in the United States, Mexico, United Kingdom, France and Italy.

For MORE NEWS BRIEFS, click here.

For a FREE SUBSCRIPTION to Expansion Management, click here.

Go to STATE SPOTLIGHTS to read more about other news and articles about this state.

Go to INDUSTRY SPOTLIGHTS to read more about other news and articles about this industry sector.

 

No talkbacks have been posted for this article.


 
More News From IW
IndustryWeek Special Reports

The Future of Manufacturing

NAM/IW Manufacturing Index

See the 50 Best U.S. Manufacturers

Search The IW US500

Search The IW1000